Comparable Benefits in Heart Failure Hospitalization and Survival with Sacubitril/Valsartan Therapy in CRT Nonresponders and HFrEF Patients Without CRT Indication.

J Clin Med · 2025 · PMC12428858 · PMID 40943860

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Both LV EF and NT-proBNP demonstrated significant improvements in patients with no composite endpoint, while those with an event also showed a marginally significant improvement in NT-proBNP, but not in LV EF.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.